Genomics, proteomics and molecular biology lead to tremendous advances in all fields of
medical sciences. Among these the finding of biomarkers as non invasive indicators of …

The past few decades are characterized by an explosive evolution of genetics and
molecular cell biology. Advances in chemistry and engineering have enabled increased …

Three common urological diseases are bladder cancer, urinary tract infection, and
hematuria. Seventeen bladder cancer biomarkers were previously discovered using iTRAQ …

Although the management of kidney transplant recipients has greatly improved over recent
decades, the assessment of individual risks remains highly imperfect. Individualized …

Renal transplantation (RT) is the preferred treatment for end-stage renal disease. However,
clinical challenges persist, ie, early detection of graft dysfunction, timely identification of …

In both research and care, patients, caregivers, and researchers are facing a leap forward in
the quantity of data that are available for analysis and interpretation, marking the daunting …

Rejection is one of the key factors that determine the long-term allograft function and survival
in renal transplant patients. Reliable and timely diagnosis is important to treat rejection as …

Background Kidney transplantation is the treatment of choice for most patients with end-
stage renal disease. To improve patient and transplant survival, non-invasive diagnostic …

Solid organ transplantation saves thousands of lives suffering from end-stage diseases.
Although early transplants experienced acute organ injury, medical breakthroughs, such as …

Chronic kidney disease (CKD) is a significant public health problem, and progression to end‐
stage renal disease leads to dramatic increases in morbidity and mortality. The mechanisms …